Delivery Order SPE2DB20D1100-SPE2DB24FD6E1

Award Date 9/4/24
Potential Completion Date 9/5/24
Potential Value $3.8K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, to provide 4,566,816,295 units of fluticasone propionate HFA 110 mcg 12 gm inhalers. The contract has a ceiling value of $1,823.85 and a period of performance through January 2, 2025. The contract is a firm fixed-price delivery order, with no set-aside designation. AmerisourceBergen holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the supply of fluticasone propionate HFA 110 mcg inhaler units. The contract has a firm fixed price of $1,764.05 and an ultimate completion date of August 21, 2024. It is not designated as a set-aside contract. This delivery order is likely part of a larger Indefinite Delivery Contract (IDC) between Amerisourcebergen and DLA Troop Support Medical,...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $3,124.90, is for the supply of 4,567,114,947 units of fluticasone propionate HFA 44 mcg inhalers. The contract has an ultimate completion date of February 3, 2025 and is a firm fixed-price delivery order. It is not set aside for any specific business type. AmerisourceBergen holds a larger...
This is a delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of fluticasone propionate HFA 110 mcg 12 gm inhalers, with a ceiling value of $2,396.16 and a completion date of November 3, 2023. The contract is a firm fixed-price delivery order, with no set-aside designation indicated. AmerisourceBergen holds a significant Indefinite...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $2,287.67, is for the delivery of fluticasone propionate HFA 110 mcg 12 gm inhalers. The contract has an ultimate completion date of October 31, 2024 and is structured as a Firm Fixed Price Delivery Order. The contract is not designated as a set-aside. AmerisourceBergen holds a significant Indefinite...
This is a $1,858.24 firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of fluticasone propionate HFA 110 mcg 12 gram inhalers, with a period of performance through June 4, 2025. This is a non-set-aside contract, indicating open competition. AmerisourceBergen Drug Corp holds a $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $3,977.92, is for the delivery of fluticasone propionate HFA 110 MCG 12GM inhalers. The contract is a firm fixed-price delivery order with an ultimate completion date of April 9, 2024. Amerisourcebergen holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical,...
This is a firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, for the supply of 4,564,015,027 units of fluticasone propionate HFA 110 mcg 12 gram inhalers. The contract has a ceiling value of $3,341.58 and a period of performance through March 20, 2024. Amerisourcebergen Drug Corp is the prime contractor and no set-aside designation was used for this award. This delivery order is issued under...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of Fluticasone Propionate HFA 110 MCG 12GM inhalers. The contract has a ceiling value of $2,071.60 and an ultimate completion date of August 12, 2024. The contract is a firm fixed-price delivery order, with no set-aside designation. AmerisourceBergen, through its Corporate Office division, has been awarded...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $11,139.54, is for the delivery of fluticasone propionate HFA 110 mcg 12 gm inhalers. The contract has a completion date of June 28, 2024 and is a firm fixed price delivery order. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support...
  • SPE2DB20D1100
    Indefinite Delivery Contract
  • SPE2DB20D1100-SPE2DB24FD6E1
    Delivery Order

This is a federal delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The contract, valued at $3,846.81, is for the supply of 4,565,680,549 units of fluticasone propionate HFA 110 mcg 12 gm inhalers. This is a firm fixed-price delivery order contract with no set-aside designation. Amerisourcebergen, through its Corporate Office division, will provide these critical respiratory medications to support military treatment facilities and federal healthcare programs. The contract has an ultimate completion date of September 5, 2024. Amerisourcebergen holds several Indefinite Delivery Contracts (IDCs) with DLA and other federal agencies, valued up to $999,999,999 and $750,000 respectively, to supply a wide range of pharmaceutical products and medical supplies to the government.

Generated 12/4/24, 9:10 AM